FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to experimental pharmacology and ophthalmology. Intramuscular injection of 2-ethyl-6-methyl-3-hydroxypyridinium 5-hydroxy-3-pyridinocarbonate at a dose of 25.5 mg/kg is performed 60 minutes after modeling excitotoxic damage to the retina. Then daily administration is performed once a day for 7 days.
EFFECT: invention provides pronounced correction of retinal microcirculatory disorders.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING EXCITOTOXIC DAMAGE OF RETINA BY DIMETHYLAMINOETHANOL DERIVATIVE IN EXPERIMENT | 2021 |
|
RU2765675C1 |
METHOD FOR CORRECTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE WITH A DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN AN EXPERIMENT | 2017 |
|
RU2663643C1 |
METHOD FOR PREVENTING MICROCIRCULATION DISORDERS IN KIDNEYS WITH ASIALISED ERYTHROPOIETIN IN EXPERIMENT | 2018 |
|
RU2696864C1 |
METHOD FOR CORRECTING MICROCIRCULATORY DISORDERS OF THE RETINA WITH ASIALATED ERYTHROPOIETIN | 2021 |
|
RU2762892C1 |
METHOD FOR CORRECTION OF MICROCIRCULATORY DISORDERS OF THE RETINA WITH LOW-SIALATED ERYTHROPOIETIN | 2021 |
|
RU2750966C1 |
METHOD FOR RETINAL ISCHEMIA-REPERFUSION PREVENTION BY MINOXIDIL IN EXPERIMENT | 2016 |
|
RU2643671C1 |
METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
METHOD FOR PREVENTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2017 |
|
RU2643579C1 |
METHOD FOR CORRECTION OF PLACENTAL MICROCIRCULATION DISORDER WITH SUBSTANCE OF 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN ADMA-LIKE MODEL OF PREECLAMPSIA | 2020 |
|
RU2735766C1 |
METHOD FOR PREVENTION OF ISCHEMIA OF RETINA EXPERIMENTALLY | 2013 |
|
RU2539630C1 |
Authors
Dates
2022-11-23—Published
2022-04-14—Filed